Influence of inhaled corticosteroids on intraocular pressure in patients with asthma and glaucoma Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002
Intraocular pressure in glaucoma patients varied considerably after nasal CPAP compared to control subjects Source: Annual Congress 2003 - Management of sleep related breathing disorders Year: 2003
The effect of inhaled fluticason propionate on intraocular pressure of patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 500s Year: 2006
Growth deceleration of children on inhaled corticosteroids is compensated for after the first 12 months of treatment Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007
Circadian variations of intra-ocular pressure (IOP) in apnoeic patients before and after nCPAP treatment Source: Annual Congress 2003 - Management of sleep related breathing disorders Year: 2003
Low dose inhaled fluticasone propionate compared with montelukast in children 6-12 years old Source: Eur Respir J 2003; 22: Suppl. 45, 535s Year: 2003
CPAP related intraocular pressure increase at night in people with and without glaucoma. Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities Year: 2018
Posterior subcapsular opacities not observed in children treated for 18 months with budesonide Turbuhaler® Source: Eur Respir J 2001; 18: Suppl. 33, 290s Year: 2001
Annual systemic and inhaled corticosteroid exposures in US patients =4 years with asthma Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021
A comparison of nebulized budesonide, intramuscular and oral dexamethasone in the treatment of croup among children aged 6-36 months Source: Eur Respir J 2003; 22: Suppl. 45, 284s Year: 2003
The effectiveness of inhaled steroids by metered dose inhaler with aerochamber and face mask for children ages 6 months to 4 years Source: Eur Respir J 2002; 20: Suppl. 38, 432s Year: 2002
Variability in AHI and mean pressure over time in OSA patients treated with APAP Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea Year: 2011
Adult height in children treated with inhaled budesonide is normal but reached late Source: Eur Respir J 2006; 28: Suppl. 50, 709s Year: 2006
Effects of CPAP on clinic blood pressure in patients with obstructive sleep apnea: 10 years follow –up Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017
Efficacy of fluticasone propionate in infants younger than two years with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005
Can response to inhaled corticosteroids in preschool children with recurrent wheezing predict asthma at age six years? Source: Annual Congress 2012 - Assessing and treating childhood asthma and allergy Year: 2012
Less than 20% of COPD patients persist with long-acting inhaled drugs for at least three years Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
Follow-up results 10 years after early intervention with budesonide or terbutaline in mild persistent asthma Source: Eur Respir J 2006; 28: Suppl. 50, 667s Year: 2006
The oral corticosteroid sparing effect of omalizumab in patients with severe chronic asthma: Is there a difference when you become 12 years old? Source: Annual Congress 2011 - Treating childhood asthma Year: 2011
Long-term continuous positive airway pressure (nCPAP) treatment maintains the improvement of insulin sensitivity in patients with OSAS after 2.8 years Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007